Skip to main content

Generation of Lymphocytic Choriomeningitis Virus Based Vaccine Vectors

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1404))

Abstract

Vaccination with a recombinant LCMV based vector expressing tumor-associated or viral antigens is a safe and versatile method to induce an immune response against tumors or viral infections. Here, we describe the generation of recombinant LCMV vectors in which the gene encoding the viral LCMV-GP was substituted with a gene of interest (vaccine antigen). This renders the vaccine vector propagation-incompetent while it preserves the property of eliciting a strong cytotoxic T cell response.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Zingernagel RM (2002) Lymphocytic choriomeningitis virus and immunology. Curr Top Microbiol Immunol 263:1–5

    Google Scholar 

  2. Zhou X, Ramachandran S, Mann M et al (2012) Role of lymphocytic choriomeningitis virus (LCMV) in understanding viral immunology: past, present and future. Viruses 4:2650–2669

    Article  CAS  Google Scholar 

  3. Armstrong C, Lillie RD (1934) Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1993 St. Louis encephalitis epidemic. Public Health Rep 49:1019–1027

    Article  Google Scholar 

  4. Fischer SA, Graham MB, Kuehnert MJ et al (2006) Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354:2235–2249

    Article  CAS  Google Scholar 

  5. Bonthius DJ, Perlman S (2007) Congenital viral infections of the brain: lessons learned from lymphocytic choriomeningitis virus in the neonatal rat. PLoS Pathog 3, e149

    Article  Google Scholar 

  6. Barton LL, Mets MB (2001) Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery. Clin Infect Dis 33:370–374

    Article  CAS  Google Scholar 

  7. Buchmeier MJ, Bowen MD, Peter CJ (2001) Arenaviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA, pp 1635–1668

    Google Scholar 

  8. Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 6:231–243

    Article  CAS  Google Scholar 

  9. Lee KJ, Perez M, Pinschewer DD et al (2002) Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol 76:6393–6397

    Article  CAS  Google Scholar 

  10. Pinschewer DD, Perez M, Sanchez AB et al (2003) Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc Natl Acad Sci U S A 100:7895–7900

    Article  CAS  Google Scholar 

  11. Flatz L, Bergthaler A, de la Torre JC et al (2006) Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc Natl Acad Sci U S A 103:4663–4668

    Article  CAS  Google Scholar 

  12. Sanchez AB, de la Torre JC (2006) Rescue of the prototypic Arenavirus LCMV entirely from plasmid. Virology 350:370–380

    Article  CAS  Google Scholar 

  13. Emonet SF, Garidou L, McGavern DB et al (2009) Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A 106:3473–3478

    Article  CAS  Google Scholar 

  14. Flatz L, Hegazy AN, Bergthaler A et al (2010) Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med 16:339–345

    Article  CAS  Google Scholar 

  15. Matter M, Pavelic V, Pinschewer DD et al (2007) Decreased tumor surveillance after adoptive T-cell therapy. Cancer Res 67:7467–7476

    Article  CAS  Google Scholar 

  16. Homann D, Teyton L, Oldstone MB (2001) Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 7:913–919

    Article  CAS  Google Scholar 

  17. Battegay M, Cooper S, Althage A et al (1991) Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods 3:191–198

    Article  Google Scholar 

  18. Ortiz-Riano E, Cheng BY, de la Torre JC et al (2013) Arenavirus reverse genetics for vaccine development. J Gen Virol 94:1175–1188

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lukas Flatz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Ring, S., Flatz, L. (2016). Generation of Lymphocytic Choriomeningitis Virus Based Vaccine Vectors. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 1404. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-3389-1_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3389-1_24

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-3388-4

  • Online ISBN: 978-1-4939-3389-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics